A citation-based method for searching scientific literature

Teresa K L Boitano, David A Barrington, Sadhvi Batra, Gerald McGwin, Taylor B Turner, Meagan B Farmer, Aimee M Brown, Michael J Straughn, Charles A Leath. Gynecol Oncol 2019
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The transfer of uninsured patients from academic to community primary care settings.
Sheldon M Retchin, Sheryl L Garland, Emmanuel A Anum. Am J Manag Care 2009
11
50

Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment.
Judy Mouchawar, Sharon Hensley-Alford, Suzanne Laurion, Jennifer Ellis, Alanna Kulchak-Rahm, Melissa L Finucane, Richard Meenan, Lisen Axell, Rebecca Pollack, Debra Ritzwoller. Genet Med 2005
68
50

Reproductive Decision-Making in Women with BRCA1/2 Mutations.
Jessica L Chan, Lauren N C Johnson, Mary D Sammel, Laura DiGiovanni, Chan Voong, Susan M Domchek, Clarisa R Gracia. J Genet Couns 2017
29
50

Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases.
Robert D Morgan, George J Burghel, Nicola Flaum, Michael Bulman, Andrew R Clamp, Jurjees Hasan, Claire L Mitchell, Helene Schlecht, Emma R Woodward, Fiona I Lallo,[...]. J Med Genet 2019
10
50

Disparities in genetics assessment for women with ovarian cancer: Can we do better?
Erica Manrriquez, Jocelyn S Chapman, Julie Mak, Amie M Blanco, Lee-May Chen. Gynecol Oncol 2018
24
50

Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients.
Allison W Kurian, Kevin C Ward, Nadia Howlader, Dennis Deapen, Ann S Hamilton, Angela Mariotto, Daniel Miller, Lynne S Penberthy, Steven J Katz. J Clin Oncol 2019
92
50

Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.
Morgan Butrick, Scott Kelly, Beth N Peshkin, George Luta, Rachel Nusbaum, Gillian W Hooker, Kristi Graves, Lisa Feeley, Claudine Isaacs, Heiddis B Valdimarsdottir,[...]. Genet Med 2015
59
50

Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast Cancer.
Carlos H Barcenas, Maryam N Shafaee, Arup K Sinha, Akshara Raghavendra, Babita Saigal, Rashmi K Murthy, Ashley H Woodson, Banu Arun. J Natl Compr Canc Netw 2018
8
50

Genetic counseling for hereditary breast and gynecologic cancer syndromes at a community hospital.
Karina M Haber, Brandon-Luke L Seagle, Barbara Drew, Shannon Morrill-Cornelius, Robert Samuelson, Sean Hostmeyer, Shohreh Shahabi. Conn Med 2014
2
50

Association of patient navigation with care coordination in an Lynch syndrome screening program.
Susan Miesfeldt, W Gregory Feero, Frances L Lucas, Karen Rasmussen. Transl Behav Med 2018
7
50

Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
Deborah Cragun, Anne Weidner, Courtney Lewis, Devon Bonner, Jongphil Kim, Susan T Vadaparampil, Tuya Pal. Cancer 2017
82
50

Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites.
Alice S Whittemore, Gail Gong, Esther M John, Valerie McGuire, Frederick P Li, Kimberly L Ostrow, Richard Dicioccio, Anna Felberg, Dee W West. Cancer Epidemiol Biomarkers Prev 2004
64
50

Awareness and acceptability of population-based screening for pathogenic BRCA variants: Do race and ethnicity matter?
Lisa A Rubinsak, Annette Kleinman, John Quillin, Sarah W Gordon, Stephanie A Sullivan, Arnethea L Sutton, Vanessa B Sheppard, Sarah M Temkin. Gynecol Oncol 2019
4
50

Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2.
Michael Dean, Joseph Boland, Meredith Yeager, Kate M Im, Lisa Garland, Maria Rodriguez-Herrera, Mylen Perez, Jason Mitchell, David Roberson, Kristine Jones,[...]. Gigascience 2015
29
50

Factors influencing patients' decisions to decline cancer genetic counseling services.
K P Geer, M E Ropka, W F Cohn, S M Jones, S Miesfeldt. J Genet Couns 2001
60
50

Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
Marc D Schwartz, Claudine Isaacs, Kristi D Graves, Elizabeth Poggi, Beth N Peshkin, Christy Gell, Clinton Finch, Scott Kelly, Kathryn L Taylor, Lauren Perley. Cancer 2012
90
50


Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.
Anne Marie McCarthy, Mirar Bristol, Susan M Domchek, Peter W Groeneveld, Younji Kim, U Nkiru Motanya, Judy A Shea, Katrina Armstrong. J Clin Oncol 2016
73
50

Referral of Ovarian Cancer Patients for Genetic Counselling by Oncologists: Need for Improvement.
Maria Teresa Ricci, Stefania Sciallero, Serafina Mammoliti, Viviana Gismondi, Marzena Franiuk, Paolo Bruzzi, Liliana Varesco. Public Health Genomics 2015
16
50

A survey of genetic counselors' strategies for addressing ethical and professional challenges in practice.
Matthew A Bower, Patricia McCarthy Veach, Dianne M Bartels, Bonnie S LeRoy. J Genet Couns 2002
36
50

A pilot study of spatial patterns in referrals to a multicentre cancer genetics service.
Vanessa Tempest, Gary Higgs, Kevin McDonald, Rachel Iredale, Tony Bater, Jonathon Gray. Community Genet 2005
2
50

Psychological adjustment among partners of women at high risk of developing breast/ovarian cancer.
Shab Mireskandari, Kerry A Sherman, Bettina Meiser, Alan J Taylor, Margaret Gleeson, Lesley Andrews, Katherine M Tucker. Genet Med 2007
10
50

The effectiveness of patient navigation to improve healthcare utilization outcomes: A meta-analysis of randomized controlled trials.
Sobia F Ali-Faisal, Tracey J F Colella, Naomi Medina-Jaudes, Lisa Benz Scott. Patient Educ Couns 2017
38
50

Evaluation of the needs and concerns of partners of women at high risk of developing breast/ovarian cancer.
Shab Mireskandari, Bettina Meiser, Kerry Sherman, Beverley J Warner, Lesley Andrews, Katherine M Tucker. Psychooncology 2006
20
50

Molecular pathogenesis of bilateral breast cancer.
Evgeny N Imyanitov, Kaido P Hanson. Cancer Lett 2003
27
50

Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
Zoe Kemp, Alice Turnbull, Shawn Yost, Sheila Seal, Shazia Mahamdallie, Emma Poyastro-Pearson, Margaret Warren-Perry, Anthony Eccleston, Min-Min Tan, Soo Hwang Teo,[...]. JAMA Netw Open 2019
24
50

Increasing utilization of cancer genetic counseling services using a patient navigator model.
Alanna Kulchak Rahm, Anna Sukhanova, Jennifer Ellis, Judy Mouchawar. J Genet Couns 2007
39
50

Role of parenting relationship quality in communicating about maternal BRCA1/2 genetic test results with children.
Tiffani A DeMarco, Beth N Peshkin, Heiddis B Valdimarsdottir, Andrea F Patenaude, Katherine A Schneider, Kenneth P Tercyak. J Genet Couns 2008
15
50

Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship.
Ketki Bhise, Samaresh Sau, Hashem Alsaab, Sushil Kumar Kashaw, Rakesh Kumar Tekade, Arun K Iyer. Ther Deliv 2017
23
50

Microfluidic affinity separation chip for selective capture and release of label-free ovarian cancer exosomes.
Colin L Hisey, Kalpana Deepa Priya Dorayappan, David E Cohn, Karuppaiyah Selvendiran, Derek J Hansford. Lab Chip 2018
55
50

Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.
Jiawei Sun, Lei Jiang, Yi Lin, Ethan Michael Gerhard, Xuehua Jiang, Li Li, Jian Yang, Zhongwei Gu. Int J Nanomedicine 2017
34
50

Nanodrug Delivery Systems for the Treatment of Ovarian Cancer.
Jonathan M Pantshwa, Pierre P D Kondiah, Yahya E Choonara, Thashree Marimuthu, Viness Pillay. Cancers (Basel) 2020
5
50

Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer.
Wei-Lei Yang, Zhen Lu, Jing Guo, Bryan M Fellman, Jing Ning, Karen H Lu, Usha Menon, Makoto Kobayashi, Samir M Hanash, Joseph Celestino,[...]. Cancer 2020
4
50


Multifunctional micellar nanomedicine for cancer therapy.
Elvin Blanco, Chase W Kessinger, Baran D Sumer, Jinming Gao. Exp Biol Med (Maywood) 2009
175
50


Can advanced-stage ovarian cancer be cured?
Steven Narod. Nat Rev Clin Oncol 2016
155
50

Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment.
Laura J Havrilesky, Gloria Broadwater, Debra M Davis, Kimberly C Nolte, J Cory Barnett, Evan R Myers, Shalini Kulasingam. Gynecol Oncol 2009
78
50

Metformin loaded phosphatidylserine nanoliposomes improve memory deficit and reduce neuroinflammation in streptozotocin-induced Alzheimer's disease model.
Partow Mirzaee Saffari, Sakineh Alijanpour, Nasrin Takzaree, Mousa Sahebgharani, Shahroo Etemad-Moghadam, Farshid Noorbakhsh, Alireza Partoazar. Life Sci 2020
12
50

Advances in ovarian cancer diagnosis: A journey from immunoassays to immunosensors.
Shikha Sharma, Ragini Raghav, Richard O'Kennedy, Sudha Srivastava. Enzyme Microb Technol 2016
6
50

Cancer Antigen 125 (CA125, MUC16) Protein Expression in the Diagnosis and Progression of Pancreatic Ductal Adenocarcinoma.
Kun Jiang, Elaine Tan, Zena Sayegh, Barbara Centeno, Mokenge Malafa, Domenico Coppola. Appl Immunohistochem Mol Morphol 2017
12
50

Cytotoxicity of Dendrimers.
Anna Janaszewska, Joanna Lazniewska, Przemysław Trzepiński, Monika Marcinkowska, Barbara Klajnert-Maculewicz. Biomolecules 2019
54
50

Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers.
György Sölétormos, Michael J Duffy, Suher Othman Abu Hassan, René H M Verheijen, Bengt Tholander, Robert C Bast, Katja N Gaarenstroom, Catharine M Sturgeon, Johannes M Bonfrer, Per Hyltoft Petersen,[...]. Int J Gynecol Cancer 2016
100
50

Paracrine signalling events in embryonic stem cell renewal mediated by affinity targeted nanoparticles.
Bruna Corradetti, Paz Freile, Steve Pells, Pierre Bagnaninchi, Jason Park, Tarek M Fahmy, Paul A de Sousa. Biomaterials 2012
17
50


Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.
Steven J Skates, Mark H Greene, Saundra S Buys, Phuong L Mai, Powel Brown, Marion Piedmonte, Gustavo Rodriguez, John O Schorge, Mark Sherman, Mary B Daly,[...]. Clin Cancer Res 2017
47
50

Curcumin-loaded chitosan-cholesterol micelles: evaluation in monolayers and 3D cancer spheroid model.
Omkara Swami Muddineti, Preeti Kumari, Eupa Ray, Balaram Ghosh, Swati Biswas. Nanomedicine (Lond) 2017
17
50

Unraveling a difficult diagnosis: the tricks for early recognition of ovarian cancer.
Pierluigi Giampaolino, Luigi Della Corte, Virginia Foreste, Salvatore G Vitale, Benito Chiofalo, Stefano Cianci, Fulvio Zullo, Giuseppe Bifulco. Minerva Med 2019
17
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.